Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Purcell

Showing results (211-220 of 226) with videos related to

Pageof 23
Sort By:
Nature|May 31, 2023
A pan-influenza antibody inhibiting neuraminidase via receptor mimicryCorey Momont, Ha V Dang, Fabrizia Zatta, et al.
NPJ Vaccines|October 6, 2025
Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccinationRuth A Purcell, Marios Koutsakos, Lukasz Kedzierski, et al.
The New England Journal of Medicine|August 4, 2021
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19Meagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Subcutaneous REGEN-COV Antibody Combination for Covid-19 PreventionMeagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.
JAMA|January 14, 2022
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical TrialMeagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical TrialMeagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical TrialSumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.
Nature Immunology|May 29, 2023
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbiditiesWuji Zhang, Lukasz Kedzierski, Brendon Y Chua, et al.
Science (New York, N.Y.)|October 20, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Pageof 23

Showing results (211-220 of 226) with videos related to

Sort By:
Pageof 23
Nature|May 31, 2023
A pan-influenza antibody inhibiting neuraminidase via receptor mimicryCorey Momont, Ha V Dang, Fabrizia Zatta, et al.
NPJ Vaccines|October 6, 2025
Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccinationRuth A Purcell, Marios Koutsakos, Lukasz Kedzierski, et al.
The New England Journal of Medicine|August 4, 2021
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19Meagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Subcutaneous REGEN-COV Antibody Combination for Covid-19 PreventionMeagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.
JAMA|January 14, 2022
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical TrialMeagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical TrialMeagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical TrialSumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.
Nature Immunology|May 29, 2023
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbiditiesWuji Zhang, Lukasz Kedzierski, Brendon Y Chua, et al.
Science (New York, N.Y.)|October 20, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Pageof 23